PMID: 9552228Apr 29, 1998Paper

Nutritional therapy in Crohn's disease

Inflammatory Bowel Diseases
M A O'Sullivan, C A O'Morain

Abstract

The value of nutritional support in the prevention and treatment of malnutrition in Crohn's disease is undisputed but its role in primary therapy continues to be debated. Controlled trials have demonstrated that enteral nutrition induces remission rates comparable to that of corticosteroid therapy in Crohn's disease and remains the treatment of choice for specific subgroups such as children with signs of growth impairment and patients with intolerable steroid-induced side effects. The mechanism by which an enteral diet induces remission in Crohn's disease is unclear. Bowel rest, reduced antigenic load, nutritional effects, the provision of trophic amino acids, modification of gut flora, intestinal permeability, or fecal pH have been proposed. Equally, the fat profile of the feed may reduce pro-inflammatory ecosanoid synthesis and thus modify disease activity. Maintaining long-term remission remains a challenge in the management of this disease. Cyclic administration of enteral diets, maintenance drug therapy, fat manipulated formulas, or fish oil therapy may be strategies to prolong diet-induced remission. In the future, nutrient derivatives that play a role in the protective processes of the intestinal mucosa may have applicat...Continue Reading

References

Apr 15, 1992·Annals of Internal Medicine·W F StensonW Beeken
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·G Gitnick
Sep 1, 1989·The Proceedings of the Nutrition Society·D B Silk, J Payne-James
Jul 27, 1985·Lancet·V A JonesJ O Hunter
May 1, 1987·Scandinavian Journal of Gastroenterology·P G PerssonG Hellers
Feb 1, 1987·Archives of Disease in Childhood·I R SandersonJ A Walker-Smith
Sep 1, 1985·JPEN. Journal of Parenteral and Enteral Nutrition·W W SoubaD W Wilmore
Feb 1, 1973·American Journal of Surgery·J E FischerJ A Ryan
Jun 23, 1984·British Medical Journal·C O'MoráinA J Levi
Nov 1, 1980·British Medical Journal·C O'MorainA J Levi
Apr 1, 1995·Gastroenterology·A M GriffithsL R Sutherland
Jan 1, 1995·Scandinavian Journal of Gastroenterology·K TeahonI Bjarnason
Jan 1, 1994·Gut·F Fernández-BañaresM A Gassull
Jul 1, 1993·JPEN. Journal of Parenteral and Enteral Nutrition·T HigashiguchiJ E Fischer
May 1, 1993·Journal of Pediatric Gastroenterology and Nutrition·B S Kirschner
Jul 1, 1993·Gut·A M GriffithsP M Sherman
Sep 1, 1993·Digestive Diseases and Sciences·F KurokiM Fujishima
Sep 1, 1995·JPEN. Journal of Parenteral and Enteral Nutrition·F Fernández-BanaresM A Gassull
Sep 1, 1995·JPEN. Journal of Parenteral and Enteral Nutrition·K TeahonI Bjarnason
Jun 13, 1996·The New England Journal of Medicine·A BelluzziM Miglioli
Mar 1, 1996·Scandinavian Journal of Gastroenterology·A MessoriF Pacini
Mar 1, 1997·Gastroenterology·A IlnyckyjC N Bernstein
Mar 1, 1997·Gastroenterology·G CavalliniP Bovo

❮ Previous
Next ❯

Citations

Mar 29, 2000·Critical Reviews in Oncology/hematology·L Balducci, M Extermann
Oct 7, 2006·Current Opinion in Gastroenterology·G Marx, E G Seidman
Mar 4, 2000·Inflammatory Bowel Diseases·B I Korelitz
May 19, 2001·Gut·M O'Sullivan, C O'Morain
Jul 31, 2008·World Journal of Gastroenterology : WJG·Paul-A Smith
May 25, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Hisashi ShigaTooru Shimosegawa
Mar 21, 2015·BioMed Research International·John K TriantafillidisApostolos E Papalois
May 1, 2003·FEMS Microbiology Ecology·Jussi VaahtovuoErkki Eerola
Sep 24, 2002·Revista do Hospital das Clínicas·Fábio Guilherme CamposDesidério R Kiss
Jul 27, 2001·Current Treatment Options in Gastroenterology·Maria O'Sullivan, Colm O'Morain
May 2, 2013·Therapeutic Advances in Gastroenterology·Clare F DonnellanSimon Lal
Nov 16, 2006·Diseases of the Colon and Rectum·Motohiro EsakiMitsuo Iida
May 20, 2004·Current Treatment Options in Gastroenterology·Maria O'Sullivan, Colm O'Morain
Feb 8, 2003·Journal of Gastroenterology·Tadao Bamba

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.